Piramal Pharma Solutions Unveils Advanced Capsule Tablet Technology for Customized Patient Treatment

Piramal Pharma Solutions Reveals Cutting-Edge Capsule Tablet Capabilities

Piramal Pharma Solutions, a global leader in contract development and manufacturing, has made significant strides in the pharmaceutical sector with its advanced tablet-in-capsule technology, successfully developing and commercializing drug delivery systems at its facilities in Pithampur and Ahmedabad, India. This initiative not only demonstrates Piramal's manufacturing capabilities but also emphasizes its commitment to patient-centric solutions.

Integrated Manufacturing Approach

The project saw a seamless transfer of technology and robust collaboration between teams at both sites, illustrating the strength and integration of Piramal's operations. Within just five months, the team at Ahmedabad’s Piramal Pharmaceutical Development Services (PPDS) successfully transitioned technology to the commercial production facility in Pithampur, ensuring readiness for the mass production of encapsulated tablets.

Dr. Brad Gold, Head of Global Formulations R&D at Piramal Pharma Solutions, highlighted the significance of this initiative, stating, "Our tablet-in-capsule technology offers unparalleled flexibility in dosing and delivery control, expediting timelines for developers while simplifying treatment regimens for patients."

Transformative Drug Delivery System

Traditional capsules typically contain a mix of active ingredients and excipients within a hard shell. While they are easy to absorb and use, their rigid dosage forms often limit flexibility, making them less ideal for treatments that require complex administration methods. In contrast, the tablet-in-capsule technology provides a unique solution where multiple active ingredients can be formulated into their own tablets or mini-tablets, which are then encapsulated together in a single shell.

This innovative approach allows for distinct coatings on mini-tablets, enabling developers to create varied release profiles for a single drug or across different medications. Moreover, it facilitates the combination of incompatible active ingredients into one capsule, enhancing adherence by reducing the frequency of doses a patient must take.

Enhancing Patient-Centric Solutions

The implementation of the tablet-in-capsule technology not only optimizes the stability of formulations but also furthers Piramal's mission to prioritize patient needs. By offering options that allow for double active ingredients in a single capsule or varying release profiles, this technology streamlines treatment protocols and boosts patient compliance with their therapeutic regimens.

Piramal Pharma Solutions is committed to developing comprehensive end-to-end solutions across the pharmaceutical lifecycle, leveraging its global infrastructure to meet client needs. With over 17 manufacturing and development sites worldwide, it is uniquely positioned to provide a wide array of services, including drug discovery, process development, and clinical supplies.

As the industry continues to evolve with increasingly complex drug delivery requirements, Piramal Pharma Solutions stands at the forefront, driving innovation through technologies that enhance patient outcomes and healthcare efficacy. This focus on patient-centric design underscores Piramal's long-term dedication to improving the global health landscape while meeting the demands of its partners and clientele efficiently.

About Piramal Pharma Solutions

Piramal Pharma Solutions is a premier contract development and manufacturing organization (CDMO) that supports the entire lifecycle of pharmaceuticals. With its strong global presence and extensive resource network, Piramal delivers an array of services from drug discovery through to commercial manufacture, ensuring that it meets the dynamic needs of the healthcare market effectively.

For more information, please visit Piramal Pharma Solutions or follow them on LinkedIn.

Photos: